CytoSorbents to Present at the 10th Annual SVB Leerink Global Healthcare Conference
MONMOUTH JUNCTION, N.J., Feb. 16, 2021 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world,…
Comments Off on CytoSorbents to Present at the 10th Annual SVB Leerink Global Healthcare Conference